Helixmith Co., Ltd (KOSDAQ:084990)

South Korea · Delayed Price · Currency is KRW

6,410.00

-110.00 (-1.69%)

Feb 27, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2013	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Pharmaceutical Research and Development Projects, Etc.	6.91B	8.93B	14.36B	10.57B	18.75B
Pharmaceutical Research and Development Projects, Etc. Growth	-22.65%	-37.83%	35.90%	-43.65%	101.53%
Consolidation Adjustments	-1.93B	-4.73B	-11.56B	-8.25B	-14.51B
Total	4.97B	4.20B	2.80B	2.32B	4.25B
Total Growth	18.38%	50.08%	20.87%	-45.48%	-4.63%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2013	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
South Korea	3.79B	3.36B	2.39B	1.95B	3.83B
South Korea Growth	12.59%	40.81%	22.64%	-49.10%	-5.04%
Asia	301.34M	157.16M	231.41M	59.74M	28.24M
Asia Growth	91.75%	-32.09%	287.35%	111.57%	-89.76%
America	886.33M	681.52M	179.94M	309.12M	450.48M
America Growth	30.05%	278.75%	-41.79%	-31.38%	199.86%
Total	4.97B	4.20B	2.80B	2.32B	4.30B
Total Growth	18.38%	50.08%	20.87%	-46.19%	-3.37%

Source: S&P Global Market Intelligence.